Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q6ZUT3: Variant p.Ser340Leu

FERM domain-containing protein 7
Gene: FRMD7
Feedback?
Variant information Variant position: help 340 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Leucine (L) at position 340 (S340L, p.Ser340Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In NYS1. Any additional useful information about the variant.


Sequence information Variant position: help 340 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 714 The length of the canonical sequence.
Location on the sequence: help SLPFERKHYPSQYHERQCRS S PDLLSDVSKQVEDLRLAYGG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SLPFERKHYPSQYHERQCRSSPDLLSDVSKQVEDLRLAYGG

Mouse                         SLPFERKQYPSQYHERQCRSSPDILSDVSKQVEDLRLTYGS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 714 FERM domain-containing protein 7



Literature citations
Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.
Tarpey P.; Thomas S.; Sarvananthan N.; Mallya U.; Lisgo S.; Talbot C.J.; Roberts E.O.; Awan M.; Surendran M.; McLean R.J.; Reinecke R.D.; Langmann A.; Lindner S.; Koch M.; Jain S.; Woodruff G.; Gale R.P.; Degg C.; Droutsas K.; Asproudis I.; Zubcov A.A.; Pieh C.; Veal C.D.; Machado R.D.; Backhouse O.C.; Baumber L.; Constantinescu C.S.; Brodsky M.C.; Hunter D.G.; Hertle R.W.; Read R.J.; Edkins S.; O'meara S.; Parker A.; Stevens C.; Teague J.; Wooster R.; Futreal P.A.; Trembath R.C.; Stratton M.R.; Raymond F.L.; Gottlob I.;
Nat. Genet. 38:1242-1244(2006)
Cited for: INVOLVEMENT IN NYS1; VARIANTS NYS1 ARG-24; GLU-24; ARG-142; ASP-221; THR-226; VAL-231; PRO-266; TYR-271; CYS-301 AND LEU-340; TISSUE SPECIFICITY; FUNCTION; DEVELOPMENTAL STAGE; The clinical and molecular genetic features of idiopathic infantile periodic alternating nystagmus.
Thomas M.G.; Crosier M.; Lindsay S.; Kumar A.; Thomas S.; Araki M.; Talbot C.J.; McLean R.J.; Surendran M.; Taylor K.; Leroy B.P.; Moore A.T.; Hunter D.G.; Hertle R.W.; Tarpey P.; Langmann A.; Lindner S.; Brandner M.; Gottlob I.;
Brain 134:892-902(2011)
Cited for: INVOLVEMENT IN NYS1; VARIANTS NYS1 SER-16; ARG-24; THR-226; VAL-231; PRO-266; SER-271; TYR-271 AND LEU-340; DEVELOPMENTAL STAGE;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.